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Available online 27 April 2011How do we inform patients eligible for repair of their
abdominal aortic aneurysm (AAA) in a way that is relevant
to them? How do we do it in an evidence-based way? The
PREFER study focuses on the relative importance of aspects
of information as perceived by patients, relatives and
surgeons regarding AAA repair.Decision-making and Patients’ Rights
Health-care workers play a crucial role in promoting and
protecting human rights. The right to health is not only
about ensuring access to health-care for all without dis-
crimination, but also about ensuring that the way health-
care is delivered promotes and protects human rights, such
as the rights to privacy, information and participation.1 The
theme of the PREFER study needs to be understood against
this background.
Patients’ rights vary in different countries and in different
jurisdictions, often depending upon prevailing cultural and
social norms. These are reflected in the patientephysician
relationship, which may be classified in different models,
such as the paternalistic model and the informative* Tel.: þ47 23 25 50 00; fax: þ47 23 25 50 10.
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doi:10.1016/j.ejvs.2011.03.009model. These models suggest different professional obliga-
tions of the physician towards the patient. For instance, in
the paternalistic model, the best interests of the patient as
judged by the clinical expert are valued above the provision
of comprehensive medical information and decision-making
power to the patient. The informative model, by contrast,
sees the patient as a consumer who is in the best position to
judge what is in his or her own interest, and thus views the
doctor as a provider of information. Despite cultural differ-
ences, there is growing international consensus that all
patients have a fundamental right to privacy, to the confi-
dentiality of their medical information, to consent to or to
refuse treatment and to be informed about relevant risk to
themofmedical procedures.2 Some countries have anchored
the rights of patients in laws requiring doctors and other
health-care workers to inform the patients about their
options and bring patients’ preferences specifically into the
decision-making process regarding treatment and care,3,4
whereas other countries are ensuring patients’ participa-
tion in other ways.
Patients have different backgrounds and the way to
inform and involve them in the decision-making process
must be customised. The provider of the information must
ensure that the information is understood and the under-
standing of the consequences of choosing one treatment
over the other is clear. Understanding risks is a difficultd by Elsevier Ltd. All rights reserved.
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explaining risks in lay terms. Tools to improve the delivery
of such information in practical, effective and time-saving
ways are being developed and evaluated also for vascular
surgery.5
The starting point of the PREFER study is the realisation
that we as health-care workers do not know what part of
the information we give is of most importance to the
patient. We might even hold information back that may be
crucial to the decision-making process for the patient, had
he or she known. The PREFER study gives us some infor-
mation about the preferences of patients of this study, in
relation to the questions asked, as the questions were
preformed. However, there may be other aspects of
treatments that are of interest to the patients; the study
did not try and unveil all concerns patients may have
regarding the decision of open surgery or endovascular
aneurysm repair (EVAR) for aortic aneurysm repair. The
PREFER study6 points out that the attitude and preferences
of the surgeon influences the way he or she gives infor-
mation to the patient, although it does not specifically
address it. Information to the patients regarding treatment
options should ideally be given objectively and without
bias. We know that the way information is given greatly
influences the patient’s understanding. Further, the
patients’ previous experiences with the health-care
system influence his/her preference and interpretation of
information.7
Evidence-based decision-making in a clinical setting can
be described as in Fig. 1.
Research evidence is ideally the basis for all decisions
regarding treatment. Updated evidence on short-term and
long-term complications and outcomes of open repair and
EVAR should be continuously reviewed, summarised and be
made readily available. Preferably, updated information
about clinical quality indicators for the hospital and even
for the individual surgeon on the specific procedure in
question should be available to the patient. Such indicators
should be presented in a uniform way by all hospitals, to
compare hospitals’ outcomes and to guide the patients in
their choice of hospital for their treatment. Research
should also address which issues are of relevance to the
patients, so that these can be sufficiently covered. A recent
survey showed for instance that information regardingFigure 1 Evidence-based decision-making practice.effects on sexual function after treatment for AAA, is not
given to 91% of the patients.8
In the decision process, the experts’ own interpretation
of the research results, and his or her own experience and
expertise is also part of the process. This evidence, the
expert-based evidence, is often ‘silent’, and both
the surgeon and patient may be more or less unaware of the
effects of it in the decision-making process. It is of impor-
tance to make this expert evidence more transparent.
Patients often want the trusted expert doctor’s opinion in
difficult decisions regarding their treatment and health,
and it is imperative to keep the scientific evidence and the
surgeons’ interpretation of it separate.
In addition to the summarised research and the expert’s
best judgement, the third element to consider for a truly
evidence-based decision is the patient’s preference. If the
patient is overwhelmed or confused with information, the
physician should ideally have methods to promote clarifying
the patients’ considerations and values and facilitate the
decision-making process. Patient centeredness is both
a value and a skill, a competency that can be taught and
trained.9
All decisions about treatment options are made within
a certain context, for example, regarding availability of
resources and expertise, geography and inherent cultural
aspects. The authors of the PREFER study have taken that
into account in their discussion of the results, so that these
may not be directly transferable to other settings. Even so,
the study illuminates the complex area of patient prefer-
ences in the treatment of AAA, and how these may differ
from the preferences of their treating physicians.
The PREFER study has asked patients both before
treatment and after treatment for AAA, and there is no
surprise that their preferences after treatment are influ-
enced by the actual treatment and the results thereof.
Interestingly, the study also included the preferences of the
relatives of patients. We know very little about the influ-
ence of relatives on patients’ preferences from the scien-
tific literature. However, from the daily clinical practice,
we know spouses and children are involved in the process,
although the information they get may sometimes be indi-
rect (given by the patient after a talk with the surgeon).
Further, patients, and maybe to a larger extent younger
relatives, inform themselves through the Internet, where
the quality of the information may be dubious. The PREFER
study emphasises the relatives’ role in the decision-making
process, making us more aware that the treating physician
should bring the relatives more openly into the process of
information and decision-making regarding treatment. The
need for more research on this subject is also evident.
The PREFER study documents that the number one
priority for patients, relatives and surgeons is avoidance of
major complications. Need for re-intervention also scored
high, for all patient groups. However, it is not easy from the
present study to understand why 76 treated patients put
less emphasis on this, and more emphasis on a hypothetical
cost of the treatment. It might be they understood the
question to imply patients having to pay for the treatment
out of their own pockets. This part of the study is somewhat
unclear and confusing.
Maybe the most striking result of this study is that the
surgeons do not put any emphasis on additional costs to the
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does not tell whether this is because the surgeons weigh the
reduction in costs for hospital stay and intensive care
treatment against the high device cost of EVAR, or whether
this just comes at the bottom of the priority list of the
elements analysed in this study. The study may be inter-
preted to document that surgeons do not feel any respon-
sibility for bringing cost into the equation when choosing
treatment, regardless of who is paying for the procedure.
Further studies into this area of decision-making in
vascular surgical treatment are needed, so that we can
inform our patients in an unbiased, relevant and truly
evidence-based way in the future. The influence of the way
information is given should be explored in more detail, as
should the influence of new sources of information, and
innovative ways of delivering high-quality information. The
PREFER study will hopefully be followed by more studies to
increase our knowledge and understanding of providing
patient information and promoting shared decision-making.
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